RORY PANEPINTO, MD
Podiatrist in METAIRIE, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: RORY PANEPINTO, MD reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 916 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
RORY PANEPINTO, MD at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Podiatrist compares to other specialties among Louisiana providers
Podiatrist share within Louisiana
Podiatrist is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RORY PANEPINTO, MD's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Podiatrist) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Podiatrist US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Podiatrist. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RORY PANEPINTO, MD is a Podiatrist provider practicing in METAIRIE, Louisiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1427003284. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RORY PANEPINTO, MD appears in the CMS NPPES registry as a Podiatrist provider holding MD credentials at 1801 CLEARVIEW PARKWAY, METAIRIE, LA, 70001, with a listed phone of (504) 264-3668. NPI 1427003284 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PANEPINTO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 916 prescription claims written by this provider, covering 421 Medicare beneficiaries and totaling roughly $85K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 6.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1427003284 |
|---|---|
| Specialty | Podiatrist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/23/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RORY PANEPINTO, MD's current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RORY PANEPINTO, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
International Life Sciences
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
4% brand-name claims vs 96% generic, on 916 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 983
- Total Day Supply
- 20,589
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $46K
- Generic Drug Cost
- $39K
- Opioid Claims
- 56 (6.1% rate)
- Antibiotic Claims
- 288
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.43
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 44, 65-74: 217, 75-84: 130, 85+: 30
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Ketoconazole | 210 |
| Amoxicillin | 77 |
| Terbinafine Hcl | 77 |
| Doxycycline Hyclate | 73 |
| Ibuprofen | 56 |
| Levofloxacin | 42 |
| Promethazine Hcl | 42 |
| Cephalexin | 38 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 |
| Clindamycin Hcl | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How RORY PANEPINTO, MD fits within the Podiatrist landscape nationally.
RORY PANEPINTO, MD's 916 claims are above the specialty average of 304.
Nearby Podiatrist Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as PANEPINTO.
Compare Podiatrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is RORY PANEPINTO, MD's specialty? ▼
How much does RORY PANEPINTO, MD prescribe under Medicare Part D? ▼
What is RORY PANEPINTO, MD's Medicare quality score? ▼
Where is RORY PANEPINTO, MD located? ▼
What is RORY PANEPINTO, MD's NPI number? ▼
Does RORY PANEPINTO, MD prescribe more brand-name or generic drugs? ▼
Does RORY PANEPINTO, MD prescribe opioids? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does RORY PANEPINTO, MD prescribe most often? ▼
Does RORY PANEPINTO, MD accept Medicare? ▼
How can I verify RORY PANEPINTO, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology